AustralieFrV1, PubMed, Corpus, bibRecord, 003501

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Identifieur interne : 003501 ( PubMed/Corpus ); précédent : 003500; suivant : 003502

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Auteurs : B. Escudier ; C. Porta ; M. Schmidinger ; F. Algaba ; J J Patard ; V. Khoo ; T. Eisen ; A. Horwich

Source :

Annals of oncology : official journal of the European Society for Medical Oncology [ 1569-8041 ] ; 2014.

RBID : pubmed:25210086

English descriptors

KwdEn :
- Carcinoma, Renal Cell (diagnosis), Carcinoma, Renal Cell (therapy), Combined Modality Therapy, Follow-Up Studies, Health Planning Guidelines, Humans, Kidney Neoplasms (diagnosis), Kidney Neoplasms (therapy), Neoplasm Staging, Prognosis, Societies, Medical (standards).
MESH :
- diagnosis : Carcinoma, Renal Cell, Kidney Neoplasms.
- standards : Societies, Medical.
- therapy : Carcinoma, Renal Cell, Kidney Neoplasms.
- Combined Modality Therapy, Follow-Up Studies, Health Planning Guidelines, Humans, Neoplasm Staging, Prognosis.

DOI: 10.1093/annonc/mdu259
PubMed: 25210086

Links to Exploration step

pubmed:25210086

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.</title>
<author><name sortKey="Escudier, B" sort="Escudier, B" uniqKey="Escudier B" first="B" last="Escudier">B. Escudier</name>
<affiliation><nlm:affiliation>Institut Gustave Roussy, Villejuif, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Porta, C" sort="Porta, C" uniqKey="Porta C" first="C" last="Porta">C. Porta</name>
<affiliation><nlm:affiliation>IRCCS San Matteo University Hospital Foundation, Pavia, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Schmidinger, M" sort="Schmidinger, M" uniqKey="Schmidinger M" first="M" last="Schmidinger">M. Schmidinger</name>
<affiliation><nlm:affiliation>Clinical Division of Oncology, Department of Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Algaba, F" sort="Algaba, F" uniqKey="Algaba F" first="F" last="Algaba">F. Algaba</name>
<affiliation><nlm:affiliation>Department of Pathology, Fundació Puigvert, Universitat Autónoma de Barcelona, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Patard, J J" sort="Patard, J J" uniqKey="Patard J" first="J J" last="Patard">J J Patard</name>
<affiliation><nlm:affiliation>CHU Bicêtre, Université Paris XI, Kremlin Bicêtre, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Khoo, V" sort="Khoo, V" uniqKey="Khoo V" first="V" last="Khoo">V. Khoo</name>
<affiliation><nlm:affiliation>Institute of Cancer Research and Royal Marsden Hospital, London, UK Monash University, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Eisen, T" sort="Eisen, T" uniqKey="Eisen T" first="T" last="Eisen">T. Eisen</name>
<affiliation><nlm:affiliation>Cambridge Biomedical Campus, Cambridge, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Horwich, A" sort="Horwich, A" uniqKey="Horwich A" first="A" last="Horwich">A. Horwich</name>
<affiliation><nlm:affiliation>Institute of Cancer Research and Royal Marsden Hospital, London, UK.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25210086</idno>
<idno type="pmid">25210086</idno>
<idno type="doi">10.1093/annonc/mdu259</idno>
<idno type="wicri:Area/PubMed/Corpus">003501</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003501</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.</title>
<author><name sortKey="Escudier, B" sort="Escudier, B" uniqKey="Escudier B" first="B" last="Escudier">B. Escudier</name>
<affiliation><nlm:affiliation>Institut Gustave Roussy, Villejuif, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Porta, C" sort="Porta, C" uniqKey="Porta C" first="C" last="Porta">C. Porta</name>
<affiliation><nlm:affiliation>IRCCS San Matteo University Hospital Foundation, Pavia, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Schmidinger, M" sort="Schmidinger, M" uniqKey="Schmidinger M" first="M" last="Schmidinger">M. Schmidinger</name>
<affiliation><nlm:affiliation>Clinical Division of Oncology, Department of Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Algaba, F" sort="Algaba, F" uniqKey="Algaba F" first="F" last="Algaba">F. Algaba</name>
<affiliation><nlm:affiliation>Department of Pathology, Fundació Puigvert, Universitat Autónoma de Barcelona, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Patard, J J" sort="Patard, J J" uniqKey="Patard J" first="J J" last="Patard">J J Patard</name>
<affiliation><nlm:affiliation>CHU Bicêtre, Université Paris XI, Kremlin Bicêtre, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Khoo, V" sort="Khoo, V" uniqKey="Khoo V" first="V" last="Khoo">V. Khoo</name>
<affiliation><nlm:affiliation>Institute of Cancer Research and Royal Marsden Hospital, London, UK Monash University, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Eisen, T" sort="Eisen, T" uniqKey="Eisen T" first="T" last="Eisen">T. Eisen</name>
<affiliation><nlm:affiliation>Cambridge Biomedical Campus, Cambridge, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Horwich, A" sort="Horwich, A" uniqKey="Horwich A" first="A" last="Horwich">A. Horwich</name>
<affiliation><nlm:affiliation>Institute of Cancer Research and Royal Marsden Hospital, London, UK.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of oncology : official journal of the European Society for Medical Oncology</title>
<idno type="eISSN">1569-8041</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Carcinoma, Renal Cell (diagnosis)</term>
<term>Carcinoma, Renal Cell (therapy)</term>
<term>Combined Modality Therapy</term>
<term>Follow-Up Studies</term>
<term>Health Planning Guidelines</term>
<term>Humans</term>
<term>Kidney Neoplasms (diagnosis)</term>
<term>Kidney Neoplasms (therapy)</term>
<term>Neoplasm Staging</term>
<term>Prognosis</term>
<term>Societies, Medical (standards)</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Carcinoma, Renal Cell</term>
<term>Kidney Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Societies, Medical</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Carcinoma, Renal Cell</term>
<term>Kidney Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Combined Modality Therapy</term>
<term>Follow-Up Studies</term>
<term>Health Planning Guidelines</term>
<term>Humans</term>
<term>Neoplasm Staging</term>
<term>Prognosis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25210086</PMID>
<DateCreated><Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>02</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>10</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1569-8041</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>25 Suppl 3</Volume>
<PubDate><Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Annals of oncology : official journal of the European Society for Medical Oncology</Title>
<ISOAbbreviation>Ann. Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.</ArticleTitle>
<Pagination><MedlinePgn>iii49-56</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/annonc/mdu259</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Escudier</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Institut Gustave Roussy, Villejuif, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Porta</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>IRCCS San Matteo University Hospital Foundation, Pavia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schmidinger</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Clinical Division of Oncology, Department of Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Algaba</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Pathology, Fundació Puigvert, Universitat Autónoma de Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Patard</LastName>
<ForeName>J J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo><Affiliation>CHU Bicêtre, Université Paris XI, Kremlin Bicêtre, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Khoo</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Institute of Cancer Research and Royal Marsden Hospital, London, UK Monash University, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Eisen</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Cambridge Biomedical Campus, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Horwich</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Institute of Cancer Research and Royal Marsden Hospital, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>ESMO Guidelines Working Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017065">Practice Guideline</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Ann Oncol</MedlineTA>
<NlmUniqueID>9007735</NlmUniqueID>
<ISSNLinking>0923-7534</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Ann Oncol. 2015 Sep;26 Suppl 5:v174-7</RefSource>
<PMID Version="1">26199393</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002292" MajorTopicYN="N">Carcinoma, Renal Cell</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006287" MajorTopicYN="N">Health Planning Guidelines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007680" MajorTopicYN="N">Kidney Neoplasms</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012955" MajorTopicYN="N">Societies, Medical</DescriptorName>
<QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
</MeshHeading>
</MeshHeadingList>
<InvestigatorList><Investigator ValidYN="Y"><LastName>Cervantes</LastName>
<ForeName>Andrés</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pentheroudakis</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Felip</LastName>
<ForeName>Enriqueta</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pavlidis</LastName>
<ForeName>Nicholas</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Stahel</LastName>
<ForeName>Rolf A</ForeName>
<Initials>RA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cardoso</LastName>
<ForeName>Fatima</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Senkus-Konefka</LastName>
<ForeName>Elzbieta</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Arnold</LastName>
<ForeName>Dirk</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rougier</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Horwich</LastName>
<ForeName>Alan</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sessa</LastName>
<ForeName>Cristiana</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Colombo</LastName>
<ForeName>Nicoletta</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Licitra</LastName>
<ForeName>Lisa</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Buske</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ladetto</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Peters</LastName>
<ForeName>Solange</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Casali</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Keilholz</LastName>
<ForeName>Ulrich</ForeName>
<Initials>U</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cherny</LastName>
<ForeName>Nathan</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Herrstedt</LastName>
<ForeName>Jørn</ForeName>
<Initials>J</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>2</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25210086</ArticleId>
<ArticleId IdType="pii">mdu259</ArticleId>
<ArticleId IdType="doi">10.1093/annonc/mdu259</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003501 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003501 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:25210086
   |texte=   Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:25210086" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki